Many factors contribute to mortality in lung cancer, including the presence of concomitant
cardiovascular disease. In the treatment of early stage of lung cancer, the presence of …

Despite the considerable advancements in chemotherapy as a cornerstone modality in
cancer treatment, the prevalence of complications and pre-existing diseases is on the rise …

Objective We aimed to develop of a risk stratification model for the pharmaceutical care of
patients with solid or hematologic neoplasms who required antineoplastic agents or …

Objectives To investigate differences in lung cancer (LC) management and survival using
data from European population cancer registries. Methods We analysed 4,602 lung cancer …

Introduction The effect of polypharmacy on older patients with cancer is unclear. This study
aimed to explore the effect of polypharmacy on the outcomes of treatment in older patients …

Background Data regarding characteristics, safety and survival outcomes of patients aged
80 or older treated with immune checkpoint inhibitors (ICI) in routine oncology practice are …

Objectives: Cancer cachexia has many effects on physical function and causes a decline in
activities of daily living (ADL). Therefore, rehabilitation programs should be structured …

Cancer survival represents one of the main indicators of interest in cancer epidemiology.
However, the survival of cancer patients can be affected by several factors, such as …

Objetivo desarrollar un modelo de estratificación de riesgo para la atención farmacéutica
(AF) de pacientes con tumores sólidos o hematológicos que requieran agentes …

Results: The results showed that almost all QoL was in the moderate category (80%). The
general health status was mostly in the moderate category (61.66%), the functional status …